Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus

Keita Matsuno, Heinz Feldmann, Hideki Ebihara

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly recognized pathogen and the first highly pathogenic tick-borne virus reported in the genus Phlebovirus, family Bunyaviridae. Except for some basic knowledge on viral biology and epidemiology as well as the establishment of diagnostics and the description of the clinical disease syndrome, little is known about this emerging pathogen. Currently, there are neither therapeutic approaches nor vaccines available for the treatment and prophylaxis of SFTSV infections. In the absence of more thorough ecology and epidemiology, prevention is based on education targeting towards avoiding exposure through ticks and blood and secretions/excretions of patients. Urgently needed are further studies on the pathogenesis and host responses to infection in order to define targets for therapeutic intervention and strategies for vaccination.

Original languageEnglish (US)
Title of host publicationEmerging Infectious Diseases
Subtitle of host publicationClinical Case Studies
PublisherElsevier Inc.
Pages1-12
Number of pages12
ISBN (Electronic)9780124201095
ISBN (Print)9780124169753
DOIs
StatePublished - May 16 2014
Externally publishedYes

Fingerprint

Orthobunyavirus
Thrombocytopenia
Fever
Ticks
Epidemiology
Phlebovirus
Bunyaviridae
Viruses
Virus Diseases
Cerebral Palsy
Ecology
Vaccination
Therapeutics
Vaccines
Education
Infection

Keywords

  • Diagnosis
  • Disease control
  • Epidemiology
  • Pathogenesis
  • Phlebovirus
  • Severe fever with thrombocytopenia syndrome virus
  • SFTSV
  • Tick-borne disease

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Matsuno, K., Feldmann, H., & Ebihara, H. (2014). Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus. In Emerging Infectious Diseases: Clinical Case Studies (pp. 1-12). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-416975-3.00001-7

Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus. / Matsuno, Keita; Feldmann, Heinz; Ebihara, Hideki.

Emerging Infectious Diseases: Clinical Case Studies. Elsevier Inc., 2014. p. 1-12.

Research output: Chapter in Book/Report/Conference proceedingChapter

Matsuno, K, Feldmann, H & Ebihara, H 2014, Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus. in Emerging Infectious Diseases: Clinical Case Studies. Elsevier Inc., pp. 1-12. https://doi.org/10.1016/B978-0-12-416975-3.00001-7
Matsuno K, Feldmann H, Ebihara H. Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus. In Emerging Infectious Diseases: Clinical Case Studies. Elsevier Inc. 2014. p. 1-12 https://doi.org/10.1016/B978-0-12-416975-3.00001-7
Matsuno, Keita ; Feldmann, Heinz ; Ebihara, Hideki. / Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus. Emerging Infectious Diseases: Clinical Case Studies. Elsevier Inc., 2014. pp. 1-12
@inbook{8be1233004e7477d9a81fb93bcc02d12,
title = "Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus",
abstract = "Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly recognized pathogen and the first highly pathogenic tick-borne virus reported in the genus Phlebovirus, family Bunyaviridae. Except for some basic knowledge on viral biology and epidemiology as well as the establishment of diagnostics and the description of the clinical disease syndrome, little is known about this emerging pathogen. Currently, there are neither therapeutic approaches nor vaccines available for the treatment and prophylaxis of SFTSV infections. In the absence of more thorough ecology and epidemiology, prevention is based on education targeting towards avoiding exposure through ticks and blood and secretions/excretions of patients. Urgently needed are further studies on the pathogenesis and host responses to infection in order to define targets for therapeutic intervention and strategies for vaccination.",
keywords = "Diagnosis, Disease control, Epidemiology, Pathogenesis, Phlebovirus, Severe fever with thrombocytopenia syndrome virus, SFTSV, Tick-borne disease",
author = "Keita Matsuno and Heinz Feldmann and Hideki Ebihara",
year = "2014",
month = "5",
day = "16",
doi = "10.1016/B978-0-12-416975-3.00001-7",
language = "English (US)",
isbn = "9780124169753",
pages = "1--12",
booktitle = "Emerging Infectious Diseases",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Severe Fever with Thrombocytopenia Syndrome Associated with a Novel Bunyavirus

AU - Matsuno, Keita

AU - Feldmann, Heinz

AU - Ebihara, Hideki

PY - 2014/5/16

Y1 - 2014/5/16

N2 - Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly recognized pathogen and the first highly pathogenic tick-borne virus reported in the genus Phlebovirus, family Bunyaviridae. Except for some basic knowledge on viral biology and epidemiology as well as the establishment of diagnostics and the description of the clinical disease syndrome, little is known about this emerging pathogen. Currently, there are neither therapeutic approaches nor vaccines available for the treatment and prophylaxis of SFTSV infections. In the absence of more thorough ecology and epidemiology, prevention is based on education targeting towards avoiding exposure through ticks and blood and secretions/excretions of patients. Urgently needed are further studies on the pathogenesis and host responses to infection in order to define targets for therapeutic intervention and strategies for vaccination.

AB - Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly recognized pathogen and the first highly pathogenic tick-borne virus reported in the genus Phlebovirus, family Bunyaviridae. Except for some basic knowledge on viral biology and epidemiology as well as the establishment of diagnostics and the description of the clinical disease syndrome, little is known about this emerging pathogen. Currently, there are neither therapeutic approaches nor vaccines available for the treatment and prophylaxis of SFTSV infections. In the absence of more thorough ecology and epidemiology, prevention is based on education targeting towards avoiding exposure through ticks and blood and secretions/excretions of patients. Urgently needed are further studies on the pathogenesis and host responses to infection in order to define targets for therapeutic intervention and strategies for vaccination.

KW - Diagnosis

KW - Disease control

KW - Epidemiology

KW - Pathogenesis

KW - Phlebovirus

KW - Severe fever with thrombocytopenia syndrome virus

KW - SFTSV

KW - Tick-borne disease

UR - http://www.scopus.com/inward/record.url?scp=84942805276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942805276&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-416975-3.00001-7

DO - 10.1016/B978-0-12-416975-3.00001-7

M3 - Chapter

AN - SCOPUS:84942805276

SN - 9780124169753

SP - 1

EP - 12

BT - Emerging Infectious Diseases

PB - Elsevier Inc.

ER -